Azitra, Inc.

AZTR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $0 $7.5K $686.0K $284.0K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $4.8M $4.7M $3.6M $6.1M
SG&A Expense $6.1M $6.3M $4.5M $3.6M
Operating Income $-11.0M $-11.0M $-7.5M $-9.5M
Operating Margin -146,468.5% -1,086.1% -3,328.7%
Interest Expense $167.7K $251.9K
Pretax Income $-10.9M $-9.0M $-11.3M $-10.7M
Income Tax Expense $8.3K $9.0K $17.3K
Net Income $-11.0M $-9.0M $-11.3M $-10.7M
Net Margin -119,566.6% -1,644.9% -3,760.7%
EPS (Basic) $-2.25 $-1.74 $-3.05 $-0.71
EPS (Diluted) $-2.25 $-1.74 $-3.05 $-0.71
Shares Outstanding (Basic) 4.9M 5.1M 4.1M 19.0M
Shares Outstanding (Diluted) 4.9M 5.1M 4.1M 19.0M
Dividends Per Share